Black CM - Search Results

1

Juvenile-onset localized scleroderma activity detection by infrared thermography.

Martini G, Murray KJ, Howell KJ, Harper J, Atherton D, Woo P, Zulian F, Black CM. Martini G, et al. Among authors: black cm. Rheumatology (Oxford). 2002 Oct;41(10):1178-82. doi: 10.1093/rheumatology/41.10.1178. Rheumatology (Oxford). 2002. PMID: 12364640

2

The use of portable radiometry to assess Raynaud's phenomenon: a practical alternative to thermal imaging.

Cherkas LF, Howell K, Carter L, Black CM, MacGregor AJ. Cherkas LF, et al. Among authors: black cm. Rheumatology (Oxford). 2001 Dec;40(12):1384-7. doi: 10.1093/rheumatology/40.12.1384. Rheumatology (Oxford). 2001. PMID: 11752509 Clinical Trial.

3

Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon.

Denton CP, Bunce TD, Dorado MB, Roberts Z, Wilson H, Howell K, Bruckdorfer KR, Black CM. Denton CP, et al. Among authors: black cm. Rheumatology (Oxford). 1999 Apr;38(4):309-15. doi: 10.1093/rheumatology/38.4.309. Rheumatology (Oxford). 1999. PMID: 10378706 Clinical Trial.

4

Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.

Coleiro B, Marshall SE, Denton CP, Howell K, Blann A, Welsh KI, Black CM. Coleiro B, et al. Among authors: black cm. Rheumatology (Oxford). 2001 Sep;40(9):1038-43. doi: 10.1093/rheumatology/40.9.1038. Rheumatology (Oxford). 2001. PMID: 11561116 Clinical Trial.

5

Long-term low molecular weight heparin therapy for severe Raynaud's phenomenon: a pilot study.

Denton CP, Howell K, Stratton RJ, Black CM. Denton CP, et al. Among authors: black cm. Clin Exp Rheumatol. 2000 Jul-Aug;18(4):499-502. Clin Exp Rheumatol. 2000. PMID: 10949727 Clinical Trial.

6

Digital sympathectomy for ischaemia in scleroderma.

Stratton R, Howell K, Goddard N, Black C. Stratton R, et al. Br J Rheumatol. 1997 Dec;36(12):1338-9. doi: 10.1093/rheumatology/36.12.1338. Br J Rheumatol. 1997. PMID: 9448600 No abstract available.

7

Childhood-onset scleroderma: is it different from adult-onset disease.

Vancheeswaran R, Black CM, David J, Hasson N, Harper J, Atherton D, Trivedi P, Woo P. Vancheeswaran R, et al. Among authors: black cm. Arthritis Rheum. 1996 Jun;39(6):1041-9. doi: 10.1002/art.1780390624. Arthritis Rheum. 1996. PMID: 8651969

8

Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients.

Stratton R, Shiwen X, Martini G, Holmes A, Leask A, Haberberger T, Martin GR, Black CM, Abraham D. Stratton R, et al. Among authors: black cm. J Clin Invest. 2001 Jul;108(2):241-50. doi: 10.1172/JCI12020. J Clin Invest. 2001. PMID: 11457877 Free PMC article. Clinical Trial.

9

A cross-sectional comparison of three self-reported functional indices in scleroderma.

Smyth AE, MacGregor AJ, Mukerjee D, Brough GM, Black CM, Denton CP. Smyth AE, et al. Among authors: black cm. Rheumatology (Oxford). 2003 Jun;42(6):732-8. doi: 10.1093/rheumatology/keg145. Epub 2003 Apr 16. Rheumatology (Oxford). 2003. PMID: 12730528

10

Arthritis in scleroderma.

Misra R, Darton K, Jewkes RF, Black CM, Maini RN. Misra R, et al. Among authors: black cm. Br J Rheumatol. 1995 Sep;34(9):831-7. doi: 10.1093/rheumatology/34.9.831. Br J Rheumatol. 1995. PMID: 7582722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

500 results

Search Page

Filters